Plasmodium falciparum adapts its investment into replication versus transmission according to the host environment

Abstract

The malaria parasite life cycle includes asexual replication in human blood, with a proportion of parasites differentiating to gametocytes required for transmission to mosquitoes. Commitment to differentiate into gametocytes, which is marked by activation of the parasite transcription factor ap2-g, is known to be influenced by host factors but a comprehensive model remains uncertain. Here we analyze data from 828 children in Kilifi, Kenya with severe, uncomplicated, and asymptomatic malaria infection over 18 years of falling malaria transmission. We examine markers of host immunity and metabolism, and markers of parasite growth and transmission investment. We find that inflammatory responses associated with reduced plasma lysophosphatidylcholine levels are associated with markers of increased investment in parasite sexual reproduction (i.e., transmission investment) and reduced growth (i.e., asexual replication). This association becomes stronger with falling transmission and suggests that parasites can rapidly respond to the within-host environment, which in turn is subject to changing transmission.

Data availability

Raw data and script for all the analyses in this manuscript are available at https://doi.org/10.7910/DVN/BXXVRY. mzML mass spectrometry files are available at MetaboLights at https://www.ebi.ac.uk/metabolights/editor/study/MTBLS5130

The following data sets were generated

Article and author information

Author details

  1. Abdirahman I Abdi

    Biosciences, KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya
    For correspondence
    aabdi@kemri-wellcome.org
    Competing interests
    The authors declare that no competing interests exist.
  2. Fiona Achcar

    Wellcome Center for Integrative Parasitology, University of Glasgow, Glasgow, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-8792-7615
  3. Lauriane Sollelis

    Wellcome Center for Integrative Parasitology, University of Glasgow, Glasgow, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  4. João Luiz Silva-Filho

    Wellcome Center for Integrative Parasitology, University of Glasgow, Glasgow, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4762-2205
  5. Kioko Mwikali

    Biosciences, KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya
    Competing interests
    The authors declare that no competing interests exist.
  6. Michelle Muthui

    Biosciences, KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya
    Competing interests
    The authors declare that no competing interests exist.
  7. Shaban Mwangi

    Biosciences, KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-1961-3205
  8. Hannah W Kimingi

    Biosciences, KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya
    Competing interests
    The authors declare that no competing interests exist.
  9. Benedict Orindi

    Biosciences, KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya
    Competing interests
    The authors declare that no competing interests exist.
  10. Cheryl Andisi

    Biosciences, KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya
    Competing interests
    The authors declare that no competing interests exist.
  11. Manon Alkema

    Medical Microbiology, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-8906-0047
  12. Amrita Chandrasekar

    Wellcome Center for Integrative Parasitology, University of Glasgow, Glasgow, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  13. Peter C Bull

    Biosciences, KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya
    Competing interests
    The authors declare that no competing interests exist.
  14. Philip Bejon

    Pathogen Vector Host Biology, KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya
    Competing interests
    The authors declare that no competing interests exist.
  15. Katarzyna Modrzynska

    Wellcome Center for Integrative Parasitology, University of Glasgow, Glasgow, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  16. Teun Bousema

    Radboud Institute for Health Sciences, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-2666-094X
  17. Matthias Marti

    Wellcome Centre for Molecular Parasitology, University of Glasgow, Glasgow, United Kingdom
    For correspondence
    matthias.marti@glasgow.ac.uk
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-1040-9566

Funding

Wellcome Trust (110166)

  • Fiona Achcar
  • Lauriane Sollelis
  • João Luiz Silva-Filho
  • Matthias Marti

Wellcome Trust (104111)

  • Fiona Achcar
  • Lauriane Sollelis
  • João Luiz Silva-Filho
  • Matthias Marti

Royal Society (Wolfson Merit Award)

  • Matthias Marti

European Research Council

  • Teun Bousema

Wellcome Trust (209289/Z/17/Z)

  • Abdirahman I Abdi

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Urszula Krzych, Walter Reed Army Institute of Research, United States

Ethics

Human subjects: Ethical approval was granted by the Scientific Ethics Review Unit of the Kenya Medical Research Institute under the protocol; KEMRI/SERU/3149, and informed consent was obtained from the parents/guardian of the children.

Version history

  1. Received: November 24, 2022
  2. Preprint posted: December 2, 2022 (view preprint)
  3. Accepted: March 1, 2023
  4. Accepted Manuscript published: March 14, 2023 (version 1)
  5. Version of Record published: March 29, 2023 (version 2)

Copyright

© 2023, Abdi et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,876
    views
  • 379
    downloads
  • 11
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Abdirahman I Abdi
  2. Fiona Achcar
  3. Lauriane Sollelis
  4. João Luiz Silva-Filho
  5. Kioko Mwikali
  6. Michelle Muthui
  7. Shaban Mwangi
  8. Hannah W Kimingi
  9. Benedict Orindi
  10. Cheryl Andisi
  11. Manon Alkema
  12. Amrita Chandrasekar
  13. Peter C Bull
  14. Philip Bejon
  15. Katarzyna Modrzynska
  16. Teun Bousema
  17. Matthias Marti
(2023)
Plasmodium falciparum adapts its investment into replication versus transmission according to the host environment
eLife 12:e85140.
https://doi.org/10.7554/eLife.85140

Share this article

https://doi.org/10.7554/eLife.85140

Further reading

    1. Microbiology and Infectious Disease
    2. Structural Biology and Molecular Biophysics
    Thomas Kuhlman
    Insight

    A new study reveals how naturally occurring mutations affect the biophysical properties of nucleocapsid proteins in SARS-CoV-2.

    1. Microbiology and Infectious Disease
    Gretchen Diffendall, Aurelie Claes ... Artur Scherf
    Research Article

    While often undetected and untreated, persistent seasonal asymptomatic malaria infections remain a global public health problem. Despite the presence of parasites in the peripheral blood, no symptoms develop. Disease severity is correlated with the levels of infected red blood cells (iRBCs) adhering within blood vessels. Changes in iRBC adhesion capacity have been linked to seasonal asymptomatic malaria infections, however how this is occurring is still unknown. Here, we present evidence that RNA polymerase III (RNA Pol III) transcription in Plasmodium falciparum is downregulated in field isolates obtained from asymptomatic individuals during the dry season. Through experiments with in vitro cultured parasites, we have uncovered an RNA Pol III-dependent mechanism that controls pathogen proliferation and expression of a major virulence factor in response to external stimuli. Our findings establish a connection between P. falciparum cytoadhesion and a non-coding RNA family transcribed by Pol III. Additionally, we have identified P. falciparum Maf1 as a pivotal regulator of Pol III transcription, both for maintaining cellular homeostasis and for responding adaptively to external signals. These results introduce a novel perspective that contributes to our understanding of P. falciparum virulence. Furthermore, they establish a connection between this regulatory process and the occurrence of seasonal asymptomatic malaria infections.